A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: Evidence for interference with some assays of lipoprotein oxidation by aminoguanidine

C. Scaccini, G. Chiesa, I. Jialal

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Several lines of evidence support a role for oxidized low density lipoprotein (LDL) in the genesis of the atherosclerotic lesion. Hence, the effect of compounds with antioxidant properties on LDL oxidation assumes great significance. Ascorbate, a potent water-soluble chain-breaking antioxidant, has been shown to inhibit LDL oxidation. Aminoguanidine (AMG) is a pharmacological inhibitor of advanced non-enzymatic glycosylation. Recently it has been suggested that aminoguanidine might have an inhibitory effect on LDL oxidation, but total lipid peroxidation assayed by conjugated diene formation was not inhibited. Thus, in this study, we compared the effect of aminoguanidine with ascorbate to obtain a better appreciation of the effect of AMG on Cu2+-catalyzed LDL oxidation. Oxidative modification of LDL was monitored by assaying intermediates and end products of lipid peroxidation, conjugated dienes (GD), lipid peroxides (LPO), and relative electrophoretic mobility (REM). Apolipoprotein B-100 modification (increased fluorescence, fragmentation on SDS-PAGE, and 125I-labeled LDL degradation by human macrophages) was also measured. Ascorbate (100 μM) inhibited LDL oxidation by > 95%, as evidenced by all of the selected indices. Aminoguanidine (20 mM) substantially decreased thiobarbituric acid-reactive substances (TBARS) activity and lipid peroxide formation, but only partially prevented the increase of REM (-55%), apoB fluorescence (-39%), and degradation by macrophages (-54%). Unlike ascorbate, AMG failed to preserve α-tocopherol in LDL, prevent apoB-100 fragmentation, or inhibit conjugated diene formation during LDL oxidation. Furthermore, incubation of AMG with already oxidized LDL resulted in a significant decrease in TBARS activity and LPO, and 26.9% decrease in the REM of LDL. Separation of AMG from LDL by gel chromatography largely restored the lipid peroxides and REM of oxidized LDL. Thus AMG interferes with these assays of lipid peroxidation. In comparison with ascorbate, which inhibits LDL oxidation at physiologic levels, the significance of a partial inhibition of some indices of LDL oxidation by high levels of aminoguanidine (20 mM) remains to be established.

Original languageEnglish (US)
Pages (from-to)1085-1092
Number of pages8
JournalJournal of Lipid Research
Volume35
Issue number6
StatePublished - 1994
Externally publishedYes

Fingerprint

LDL Lipoproteins
Lipoproteins
Assays
Oxidation
Electrophoretic mobility
Lipid Peroxides
Lipid Peroxidation
Apolipoprotein B-100
Thiobarbituric Acid Reactive Substances
Macrophages
Lipids
pimagedine
Antioxidants
Fluorescence
Glycosylation
Degradation
Tocopherols
Apolipoproteins B
Corrosion inhibitors
Chromatography

Keywords

  • aminoguanidine
  • apoB
  • ascorbate
  • LDL oxidation

ASJC Scopus subject areas

  • Endocrinology

Cite this

@article{8df534252e9641dfb96181d84563122f,
title = "A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: Evidence for interference with some assays of lipoprotein oxidation by aminoguanidine",
abstract = "Several lines of evidence support a role for oxidized low density lipoprotein (LDL) in the genesis of the atherosclerotic lesion. Hence, the effect of compounds with antioxidant properties on LDL oxidation assumes great significance. Ascorbate, a potent water-soluble chain-breaking antioxidant, has been shown to inhibit LDL oxidation. Aminoguanidine (AMG) is a pharmacological inhibitor of advanced non-enzymatic glycosylation. Recently it has been suggested that aminoguanidine might have an inhibitory effect on LDL oxidation, but total lipid peroxidation assayed by conjugated diene formation was not inhibited. Thus, in this study, we compared the effect of aminoguanidine with ascorbate to obtain a better appreciation of the effect of AMG on Cu2+-catalyzed LDL oxidation. Oxidative modification of LDL was monitored by assaying intermediates and end products of lipid peroxidation, conjugated dienes (GD), lipid peroxides (LPO), and relative electrophoretic mobility (REM). Apolipoprotein B-100 modification (increased fluorescence, fragmentation on SDS-PAGE, and 125I-labeled LDL degradation by human macrophages) was also measured. Ascorbate (100 μM) inhibited LDL oxidation by > 95{\%}, as evidenced by all of the selected indices. Aminoguanidine (20 mM) substantially decreased thiobarbituric acid-reactive substances (TBARS) activity and lipid peroxide formation, but only partially prevented the increase of REM (-55{\%}), apoB fluorescence (-39{\%}), and degradation by macrophages (-54{\%}). Unlike ascorbate, AMG failed to preserve α-tocopherol in LDL, prevent apoB-100 fragmentation, or inhibit conjugated diene formation during LDL oxidation. Furthermore, incubation of AMG with already oxidized LDL resulted in a significant decrease in TBARS activity and LPO, and 26.9{\%} decrease in the REM of LDL. Separation of AMG from LDL by gel chromatography largely restored the lipid peroxides and REM of oxidized LDL. Thus AMG interferes with these assays of lipid peroxidation. In comparison with ascorbate, which inhibits LDL oxidation at physiologic levels, the significance of a partial inhibition of some indices of LDL oxidation by high levels of aminoguanidine (20 mM) remains to be established.",
keywords = "aminoguanidine, apoB, ascorbate, LDL oxidation",
author = "C. Scaccini and G. Chiesa and I. Jialal",
year = "1994",
language = "English (US)",
volume = "35",
pages = "1085--1092",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL

T2 - Evidence for interference with some assays of lipoprotein oxidation by aminoguanidine

AU - Scaccini, C.

AU - Chiesa, G.

AU - Jialal, I.

PY - 1994

Y1 - 1994

N2 - Several lines of evidence support a role for oxidized low density lipoprotein (LDL) in the genesis of the atherosclerotic lesion. Hence, the effect of compounds with antioxidant properties on LDL oxidation assumes great significance. Ascorbate, a potent water-soluble chain-breaking antioxidant, has been shown to inhibit LDL oxidation. Aminoguanidine (AMG) is a pharmacological inhibitor of advanced non-enzymatic glycosylation. Recently it has been suggested that aminoguanidine might have an inhibitory effect on LDL oxidation, but total lipid peroxidation assayed by conjugated diene formation was not inhibited. Thus, in this study, we compared the effect of aminoguanidine with ascorbate to obtain a better appreciation of the effect of AMG on Cu2+-catalyzed LDL oxidation. Oxidative modification of LDL was monitored by assaying intermediates and end products of lipid peroxidation, conjugated dienes (GD), lipid peroxides (LPO), and relative electrophoretic mobility (REM). Apolipoprotein B-100 modification (increased fluorescence, fragmentation on SDS-PAGE, and 125I-labeled LDL degradation by human macrophages) was also measured. Ascorbate (100 μM) inhibited LDL oxidation by > 95%, as evidenced by all of the selected indices. Aminoguanidine (20 mM) substantially decreased thiobarbituric acid-reactive substances (TBARS) activity and lipid peroxide formation, but only partially prevented the increase of REM (-55%), apoB fluorescence (-39%), and degradation by macrophages (-54%). Unlike ascorbate, AMG failed to preserve α-tocopherol in LDL, prevent apoB-100 fragmentation, or inhibit conjugated diene formation during LDL oxidation. Furthermore, incubation of AMG with already oxidized LDL resulted in a significant decrease in TBARS activity and LPO, and 26.9% decrease in the REM of LDL. Separation of AMG from LDL by gel chromatography largely restored the lipid peroxides and REM of oxidized LDL. Thus AMG interferes with these assays of lipid peroxidation. In comparison with ascorbate, which inhibits LDL oxidation at physiologic levels, the significance of a partial inhibition of some indices of LDL oxidation by high levels of aminoguanidine (20 mM) remains to be established.

AB - Several lines of evidence support a role for oxidized low density lipoprotein (LDL) in the genesis of the atherosclerotic lesion. Hence, the effect of compounds with antioxidant properties on LDL oxidation assumes great significance. Ascorbate, a potent water-soluble chain-breaking antioxidant, has been shown to inhibit LDL oxidation. Aminoguanidine (AMG) is a pharmacological inhibitor of advanced non-enzymatic glycosylation. Recently it has been suggested that aminoguanidine might have an inhibitory effect on LDL oxidation, but total lipid peroxidation assayed by conjugated diene formation was not inhibited. Thus, in this study, we compared the effect of aminoguanidine with ascorbate to obtain a better appreciation of the effect of AMG on Cu2+-catalyzed LDL oxidation. Oxidative modification of LDL was monitored by assaying intermediates and end products of lipid peroxidation, conjugated dienes (GD), lipid peroxides (LPO), and relative electrophoretic mobility (REM). Apolipoprotein B-100 modification (increased fluorescence, fragmentation on SDS-PAGE, and 125I-labeled LDL degradation by human macrophages) was also measured. Ascorbate (100 μM) inhibited LDL oxidation by > 95%, as evidenced by all of the selected indices. Aminoguanidine (20 mM) substantially decreased thiobarbituric acid-reactive substances (TBARS) activity and lipid peroxide formation, but only partially prevented the increase of REM (-55%), apoB fluorescence (-39%), and degradation by macrophages (-54%). Unlike ascorbate, AMG failed to preserve α-tocopherol in LDL, prevent apoB-100 fragmentation, or inhibit conjugated diene formation during LDL oxidation. Furthermore, incubation of AMG with already oxidized LDL resulted in a significant decrease in TBARS activity and LPO, and 26.9% decrease in the REM of LDL. Separation of AMG from LDL by gel chromatography largely restored the lipid peroxides and REM of oxidized LDL. Thus AMG interferes with these assays of lipid peroxidation. In comparison with ascorbate, which inhibits LDL oxidation at physiologic levels, the significance of a partial inhibition of some indices of LDL oxidation by high levels of aminoguanidine (20 mM) remains to be established.

KW - aminoguanidine

KW - apoB

KW - ascorbate

KW - LDL oxidation

UR - http://www.scopus.com/inward/record.url?scp=0028198838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028198838&partnerID=8YFLogxK

M3 - Article

C2 - 8077847

AN - SCOPUS:0028198838

VL - 35

SP - 1085

EP - 1092

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 6

ER -